Drug Profile
Copper sulfate ophthalmic - iVeena Delivery Systems
Alternative Names: Copper sulfate eye drops - iVeena Delivery Systems; IVMED-80Latest Information Update: 15 Nov 2022
Price :
$50
*
At a glance
- Originator iVeena Delivery Systems
- Class Contraceptives; Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Keratoconus
Most Recent Events
- 15 Nov 2022 Chemical structure information added
- 25 Aug 2022 iVeena Delivery Systems enters into a strategic licensing agreement with Glaukos Corporation to develop and commercialize IVMED 80 for Keratoconus globally
- 27 Oct 2020 Topline adverse events and pharmacokinetics data from a phase I/II trial in Keratoconus released by iVeena